15^th International Conference on Tissue Engineering and Regenerative Medicine March 18-19, 2020 Paris, France

Dr. Mironov studied Medicine at the Ivanovo Sate Medical University, Ivanovo, Russia and graduated as MD in 1977. He received his PhD degree in Developmental Biology 1980 at the Moscow Pirogov State Medical Institute in 1980. After that he worked at different position in Germany, USA and Brazil. Last 5 years he serves as Chief Scientific Officer of private bioprinting company 3D Bioprinting Solutions, Moscow, Russia. He bioprinted world first functional vascularized mouse organ – mouse thyroid gland in 2015 and bioprinted a first 3D tissue (human cartilage) in Space at the International Space Station in December of 2018.

3D Bio printing, 3D Tissue regeneration

José Luis Carrillo Gamboa has completed his PhD from National Autonomous University of México in the School of Medicine. He is the Director and Founder of Mexico. He is an Academic Coordinator in Orthopedics at Hospital H+ Querétaro and; advisory member of University of Valley of México. He has published results in osteoarthritis with stem cells.

Regenerative Medicine, 3D Bio printing

Dr Kampon Sriwatanakul is the president of Vita Stem Co. Ltd., Bangkok and an internationally recognized pioneer of stem cell therapy. He is currently engaged in research and development projects related to the application of mesenchymal stem cell in the anti-aging and regenerative medicine.

Stem Cell Therapy, Regenerative Medicine

Alain Chapel is a Scientific Investigator at IRSN, Laboratory of Radiopathology and Experimental Therapies.For 25 years, he has been developing gene and cell therapy using non-human primates, immune-tolerant mice and rats to protect against the side effects of radiation. He collaborates with clinicians to develop strategies for treatment of patients after radiotherapy overexposures. He has participated in the first establishment of proof of concept of the therapeutic efficacy of Mesenchymal stem cells (MSCs) for the treatment of hematopoietic deficit, radiodermatitis and over dosages of radiotherapy. He has contributed to the first reported correction of deficient hematopoiesis in patients (graft failure and aplastic anemia) thanks to intravenous injection of MSCs restoring the bone marrow microenvironment, mandatory to sustain hematopoiesis after total body irradiation. He is scientific investigator of Clinical phase II trial evaluating the efficacy of systemic MSC injections for the treatment of severe and chronic radiotherapy-induced abdomino-pelvic complications refractory to standard therapy (NCT02814864Hirsch Index 26.

Regenerative medicine, Cell therapy, scaffold, radiotherapy

Dr.Omid Panahi , Graduated from Centro Escolar University on 2013 in field of Doctor of Dental Mediciene( DMD), and MSc Oral and maxillofacial surgery at yeditepe university, Istanbul, turkey. He has published more than 40 papers in reputed journals and has been serving as an editorial board member of isi journals.

Oral implant, Oral surgery, Regenerative dentistry